Product Manager - Vaccines
About the job
- A bachelor's degree in Science or a related field is required.
- A minimum of 5 years of experience in the pharmaceutical industry is required.
- A minimum of 3 years of marketing experience is required.
- Proficiency in digital marketing platforms, programmatic advertising, and AI-driven marketing tools is required.
- Fluency in English and Chinese (Cantonese and Mandarin) is required.
- Brand planning and positioning across short- and long-term horizons, competitive analysis, and market defense strategy development are required.
- Marketing execution, sales collaboration, budget management, forecasting accuracy, and project prioritization are required.
- KOL engagement and cross-functional collaboration with healthcare professionals and policy makers are required.
- Strong presentation skills are required.
- Adaptability, a patient-centric approach, results orientation, and commitment to ethical marketing and compliance standards are required.
- Develop and execute marketing plans to optimize brand value across the vaccine portfolio, build market leadership positions, conduct competitive intelligence, and develop approaches to expand vaccination coverage and grow patient numbers on Sanofi products.
- Build and maintain strategic relationships with key opinion leaders in vaccines and pediatrics, and engage healthcare policy makers and medical associations to shape the vaccination landscape and reinforce brand positioning.
- Leverage company digital assets to enhance business performance and customer engagement, implement patient-driven education through digital channels, and use data analytics to translate insights into actionable strategies.
- Partner with the Sales team to set targets and define field activities, develop sales training materials, prepare annual forecasts and budgets, and monitor monthly sales performance and A&P expenditure.
- Ensure marketing activities comply with company guidelines and HKAPI regulations, and assess compliance risks in collaboration with Medical, Regulatory Affairs, and Public Affairs teams before implementation.
- Lead cross-functional initiatives and develop patient-centric campaigns with public relations and communications to drive vaccination awareness and improve public health outcomes in Hong Kong.
- An MBA or advanced degree is preferred.
- Infectious Disease or pediatric KOL connections are preferred.
- A track record of market leadership, share growth, and managing multiple product franchises is an advantage.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave